Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Chanda Sanjay
Chief Development Officer at AN2 Therapeutics. Filing since 3 Jan 2025.
CIK 0001571820
Company
Date
Role
Action
Shares
Amount
Of holding
ANTX
AN2 Therapeutics, Inc.
6 Jan 2026
Chief Development Officer
Sold at will
5,956
$6.03K
7.3%
ANTX
AN2 Therapeutics, Inc.
5 Jan 2026
Chief Development Officer
Sold at will
3,295
$3.30K
3.9%
ANTX
AN2 Therapeutics, Inc.
3 Jan 2025
Chief Development Officer
Sold at will
2,957
$3.97K
9.0%
3 decisions on file.
